Purchase Order 75N95024P00239
Award Date
4/24/24
Potential Completion Date
8/23/24
Potential Value
$23K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Synthego Corporation
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94063, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $146,665.75 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of goods. The contract was not set aside. Synthego, headquartered in Redwood City, California, is providing genome engineering solutions, including cell line engineering, CRISPR libraries, and other biological...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Synthego Corporation, a small disadvantaged business, for IPSC engineering services. The firm-fixed-price contract, valued at $1,939,814.20, does not have a set-aside designation. Through this contract, Synthego will provide the NIH with various gene editing products and services, including custom cell clones,...
This is a $60,132.50 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for the provision of a Whole Human Genome Arrayed CRISPR Screening Library to support NCATS' translational science research efforts. This award is not associated with a...
This is a $25,150.00 firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR genome engineering and related services to support biomedical research efforts across multiple NIH institutes. Synthego specializes in custom cell line development, gene...
This is a $12,775 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for Synthego to provide knock-in cell line generation services to support cell biology experiments for Dr. Martina. While this contract is not set aside, Synthego has previously been awarded over 30 prime federal...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price Purchase Order to Synthego Corporation, a self-certified small disadvantaged business, for the delivery of KNOCKIN-SMALL, CELL CLONE, IMMORTALIZED with a potential value of $12,950.00. This order is part of Synthego's extensive portfolio of federal contracts to provide gene editing products, cell line engineering, and research support services...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Synthego Corporation, a small disadvantaged business, for the development of induced pluripotent stem (iPS) report cell lines expressing HiBiT at specified target genes. The $235,150.00 contract has a 20-24 week period of performance and does not have a set-aside designation. The work will be performed at Synthego's...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order contract to Synthego Corporation, a self-certified small disadvantaged business, for $188,840.00 to provide gene editing services. The contract is for the delivery of GMP-like CRISPRevolution modified single guide RNA (mod-sgRNA) sequences to support ongoing research within the LCIM program. The agency determined Synthego to...
This is a federal contract award by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products based in Redwood City, California. The contract is a $46,600 firm fixed-price purchase order with a completion date of November 15, 2020. The contract does not have a set-aside designation. Synthego specializes in providing genome engineering solutions, including...
This $235,150 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Synthego Corporation, a small disadvantaged business headquartered in Redwood City, California. The contract is for the development of induced pluripotent stem (iPS) cell lines expressing a HiBiT reporter tag at specified genes related to the NIH's Helping to End Addiction Long-term (HEAL) initiative. Synthego has a history of providing gene editing services and cell line engineering to...